Orthofix
Global spine and orthopedics company that designs and commercializes 3D-printed titanium interbody implants (e.g., WaveForm A, FORZA) with porous bone-ingrowth surfaces for spinal fusion surgery.
- CEO / Founder
- Massimo Calafiore
- Team Size
- 1001-5000
- Stage
- Public
- Total Funding
- $100M
- Latest Round
- Strategic Investment
- Key Investors
- CIP Merchant Capital Limited
Technology & Products
Key Products
WaveForm A 3D-printed anterior lumbar interbody; FORZA Titanium TLIF Spacer System; FORZA Titanium PLIF Spacer System; 7D FLASH Navigation System; Biologics and bone growth therapies
Technological Advantage
Orthofix leverages additive manufacturing to produce titanium spinal implants with complex porous geometries that are difficult to machine, supported by FDA-cleared designs (WaveForm A, FORZA). The advantage is partly protectable through design patents and regulatory clearances, though the AM process itself is widely available.
Differentiation
Value Proposition
3D-printed titanium interbody spacers with Nanovate surface technology promote osseointegration and fusion, potentially reducing reoperation rates and improving patient outcomes, while streamlining surgical workflow.
How They Differentiate
Orthofix's 3D-printed titanium spacers feature Nanovate surface technology for osseointegration, and the company integrates spine hardware, biologics, and navigation (7D FLASH) in one portfolio. Compared to Stryker's Tritanium and Zimmer's 3D-printed lines, Orthofix focuses specifically on spine and extremities, enabling faster product cycles and targeted surgeon education.
Market & Competition
Target Customers
Spine and orthopedic surgeons, hospitals, ambulatory surgery centers, healthcare providers
Industry Verticals
Medical; Spine; Orthopedics
Competitors
Stryker Corporation; Zimmer Biomet Holdings, Inc.; Globus Medical, Inc.
Growth & Milestones
Growth Metrics
Post-merger pro forma revenue ~$700M (2023); Q4 2025 revenue $219.9M (+2% reported, +3% pro forma constant currency); ~1,600 employees after SeaSpine merger.
Major Milestones
Founded in Verona, Italy (1980); FDA clearance and first patient implant of FORZA Titanium TLIF Spacer System (2021); Completed merger of equals with SeaSpine (2023); Acquired 7D Surgical for navigation technology (2023); Full commercial launch of WaveForm A 3D-printed ALIF (2023); Commercial partnership with MRIguidance (2024)
Notable Customers
Rush University Medical Center; Texas Back Institute
Funding rounds
- Debt$100M2023-10Source: PR